PL3408276T3 - 5’-tiofosforanowe analogi końca 5’ mRNA (kapu), mRNA je zawierające, sposób ich otrzymywania i zastosowania - Google Patents

5’-tiofosforanowe analogi końca 5’ mRNA (kapu), mRNA je zawierające, sposób ich otrzymywania i zastosowania

Info

Publication number
PL3408276T3
PL3408276T3 PL17712541T PL17712541T PL3408276T3 PL 3408276 T3 PL3408276 T3 PL 3408276T3 PL 17712541 T PL17712541 T PL 17712541T PL 17712541 T PL17712541 T PL 17712541T PL 3408276 T3 PL3408276 T3 PL 3408276T3
Authority
PL
Poland
Prior art keywords
mrna
phosphorothiolate
analogs
cap
obtaining
Prior art date
Application number
PL17712541T
Other languages
English (en)
Inventor
Jacek Jemielity
Kaja FAC-DĄBROWSKA
Błażej WOJTCZAK
Marek Baranowski
Anna NOWICKA
Joanna Kowalska
Paweł SIKORSKI
Marcin WARMIŃSKI
Original Assignee
Uniwersytet Warszawski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Warszawski filed Critical Uniwersytet Warszawski
Publication of PL3408276T3 publication Critical patent/PL3408276T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/02—Phosphorylation
    • C07H1/04—Introducing polyphosphoric acid radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL17712541T 2016-01-29 2017-01-27 5’-tiofosforanowe analogi końca 5’ mRNA (kapu), mRNA je zawierające, sposób ich otrzymywania i zastosowania PL3408276T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PL415967A PL415967A1 (pl) 2016-01-29 2016-01-29 5'-tiofosforanowe analogi końca 5' mRNA (kapu), sposób ich otrzymywania i zastosowanie
PCT/IB2017/050447 WO2017130151A1 (en) 2016-01-29 2017-01-27 5'-phosphorothiolate mrna 5'-end (cap) analogs, mrna comprising the same, method of obtaining and uses thereof
EP17712541.6A EP3408276B1 (en) 2016-01-29 2017-01-27 5'-phosphorothiolate mrna 5'-end (cap) analogs, mrna comprising the same, method of obtaining and uses thereof

Publications (1)

Publication Number Publication Date
PL3408276T3 true PL3408276T3 (pl) 2021-10-25

Family

ID=58387852

Family Applications (2)

Application Number Title Priority Date Filing Date
PL415967A PL415967A1 (pl) 2016-01-29 2016-01-29 5'-tiofosforanowe analogi końca 5' mRNA (kapu), sposób ich otrzymywania i zastosowanie
PL17712541T PL3408276T3 (pl) 2016-01-29 2017-01-27 5’-tiofosforanowe analogi końca 5’ mRNA (kapu), mRNA je zawierające, sposób ich otrzymywania i zastosowania

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL415967A PL415967A1 (pl) 2016-01-29 2016-01-29 5'-tiofosforanowe analogi końca 5' mRNA (kapu), sposób ich otrzymywania i zastosowanie

Country Status (11)

Country Link
US (1) US11066436B2 (pl)
EP (1) EP3408276B1 (pl)
JP (1) JP7144050B2 (pl)
KR (1) KR20180100595A (pl)
CN (1) CN109071589A (pl)
AU (1) AU2017211693B2 (pl)
CA (1) CA3011663C (pl)
EA (1) EA038834B1 (pl)
ES (1) ES2879802T3 (pl)
PL (2) PL415967A1 (pl)
WO (1) WO2017130151A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2597423A (en) * 2019-05-10 2022-01-26 New England Biolabs Inc Chemical capping for template switching
CN110907358B (zh) * 2019-12-09 2022-08-30 福建师范大学 一种光微流微泡腔铅离子传感器的实现装置及方法
CN113337559A (zh) * 2020-08-20 2021-09-03 深圳市瑞吉生物科技有限公司 一种Cap2结构5′帽子类似物及其制备方法和应用
WO2023167880A2 (en) * 2022-03-01 2023-09-07 Verve Therapeutics, Inc. Compositions and methods for capping rnas
CN114685588B (zh) * 2022-05-05 2024-03-29 江苏申基生物科技有限公司 一种含开环核苷结构的起始加帽寡核苷酸引物
CN116143855B (zh) * 2022-11-08 2023-11-28 江苏申基生物科技有限公司 一种乙烯基膦酸修饰的mRNA帽类似物及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7645866B2 (en) * 2005-06-28 2010-01-12 Life Technologies Corporation Methods of producing and sequencing modified polynucleotides
EA017740B1 (ru) * 2007-06-19 2013-02-28 Борд Оф Сьюпервайзорз Оф Луизиана Стэйт Юниверсити Энд Эгрикалчурал Энд Мекэникал Колледж Синтез и применение антиинвертированных фосфоротиоатных аналогов кэп-структуры матричной phk
PL215513B1 (pl) * 2008-06-06 2013-12-31 Univ Warszawski Nowe boranofosforanowe analogi dinukleotydów, ich zastosowanie, czasteczka RNA, sposób otrzymywania RNA oraz sposób otrzymywania peptydów lub bialka
EP2281579A1 (en) * 2009-08-05 2011-02-09 BioNTech AG Vaccine composition comprising 5'-Cap modified RNA
RS59991B1 (sr) * 2013-08-08 2020-04-30 Scripps Research Inst Metoda enzimskog in vitro obeležavanja specifičnog za položaj nukleinskih kiselina uvođenjem neprirodnih nukleotida

Also Published As

Publication number Publication date
PL415967A1 (pl) 2017-07-31
JP2019504837A (ja) 2019-02-21
CN109071589A (zh) 2018-12-21
JP7144050B2 (ja) 2022-09-29
AU2017211693B2 (en) 2021-09-09
CA3011663A1 (en) 2017-08-03
EP3408276B1 (en) 2021-04-07
US20190300563A1 (en) 2019-10-03
EA201891429A1 (ru) 2019-02-28
KR20180100595A (ko) 2018-09-11
EP3408276A1 (en) 2018-12-05
WO2017130151A1 (en) 2017-08-03
US11066436B2 (en) 2021-07-20
ES2879802T3 (es) 2021-11-23
CA3011663C (en) 2023-10-31
AU2017211693A1 (en) 2018-08-09
EA038834B1 (ru) 2021-10-26

Similar Documents

Publication Publication Date Title
IL288418A (en) 4'-phosphate analogs and oligonucleotides containing them
IL256395B (en) Stabilized antimicrobial peptides, preparations containing them and methods of producing them
HK1250035A1 (zh) 抗cd 71抗體，可活化抗cd 71抗體及其使用方法
IL275055A (en) Tertiary antibody, method for its preparation and use
PL3408276T3 (pl) 5’-tiofosforanowe analogi końca 5’ mRNA (kapu), mRNA je zawierające, sposób ich otrzymywania i zastosowania
IL290633A (en) 5'-cyclophosphonate modified nucleotides, preparations containing them and their uses
GB2555362B (en) Novel dissymmetric N, N-dialkylamides, the synthesis thereof and uses of same
PL3309138T3 (pl) Sposób koprodukcji 2,3,3,3-tetrafluoropropylenu i 1,3,3,3-tetrafluoropropylenu
SG11201900459RA (en) Mg53 mutants, methods of making the same, and uses thereof
ZA201903928B (en) Compositions comprising methylphenidate-prodrugs, processes of making and using the same
SG11202106282RA (en) Biochip, method of preparation and use thereof
SG11202001195PA (en) Gyroscope, methods of forming and operating the same
SG11201803581VA (en) Chimeric RSV, Immunogenic Compositions, and Methods of Use
EP3112351A4 (en) Naphthylamide compound, preparation method and use thereof
IL256350A (en) Compositions and methods for the treatment of substance use disorders, addiction, and psychiatric disorders
HK1254379A1 (zh) 烯基苯氧基取代的1，1-二苯基乙烯、它們的製備方法和它們的用途
HK1246215A1 (zh) 去細胞角膜及其製備方法和用途
IL254578A0 (en) Abscisic acid (s)-2' vinyl derivatives
EP3378913C0 (en) USE OF SIGNAL LABELS AND THEIR MANUFACTURING METHOD
EP3448857A4 (en) ANALOGUE OF YOHIMBIN AND USES THEREOF
EP3470403A4 (en) NOVEL TAXOID COMPOUND, PREPARATION METHOD AND USE THEREOF
HK1217507A1 (zh) 納米二氧化鈦功能塗料、其製備方法、由其製備的基材以及所述基材的製備方法
HUE057090T2 (hu) BI-heteroaril-szubsztituált 1,4-benzodiazepinek és alkalmazásuk rák kezelésében
EP3293179A4 (en) Amide compound and the preparation method and use thereof
HK1259196A1 (zh) 延遲釋放製劑、其製備方法和用途